title: Fetal hepatic and umbilical uptakes of glucogenic substrates during a glucagon-somatostatin infusion.
abstract: To test the hypothesis that fetal hepatic glutamate output diverts the products of hepatic amino acid metabolism from hepatic gluconeogenesis, ovine fetal hepatic and umbilical uptakes of glucose and glucogenic substrates were measured before and during fetal glucagon-somatostatin (GS) infusion and during the combined infusion of GS, alanine, glutamine, and arginine. Before the infusions, hepatic uptake of lactate, alanine, glutamine, arginine, and other substrates was accompanied by hepatic output of pyruvate, aspartate, serine, glutamate, and ornithine. The GS infusion induced hepatic output of 1.00 +/- 0.07 mol glucose carbon/mol O(2) uptake, an equivalent reduction in hepatic output of pyruvate and glutamate carbon, a decrease in umbilical glucose uptake and placental uptake of fetal glutamate, an increase in hepatic alanine and arginine clearances, and a decrease in umbilical alanine, glutamine, and arginine uptakes. The latter result suggests that glucagon inhibits umbilical amino acid uptake. We conclude that fetal hepatic pyruvate and glutamate output is part of an adaptation to placental function that requires the fetal liver to maintain both a high rate of catabolism of glucogenic substrates and a low rate of gluconeogenesis.
authors.affiliation: Departments of Pediatrics and Physiology, University of Colorado School of Medicine, Aurora, Colorado, 80045-0508, USA.
authors.forename: Cecilia
authors.initials: C
authors.lastname: Teng
authors.forename: Frederick C
authors.initials: FC
authors.lastname: Battaglia
authors.forename: Giacomo
authors.initials: G
authors.lastname: Meschia
authors.forename: Michael R
authors.initials: MR
authors.lastname: Narkewicz
authors.forename: Randall B
authors.initials: RB
authors.lastname: Wilkening
mesh_terms: D000409:Alanine / Q000008:administration & dosage / Q000378:metabolism; D000818:Animals; D001120:Arginine / Q000008:administration & dosage; D001786:Blood Glucose / Q000378:metabolism; D005260:Female; D005312:Fetal Blood / Q000378:metabolism; D005865:Gestational Age; D005934:Glucagon / Q000008:administration & dosage*; D005943:Gluconeogenesis; D005947:Glucose / Q000378:metabolism*; D005973:Glutamine / Q000008:administration & dosage / Q000378:metabolism; D019344:Lactic Acid / Q000378:metabolism; D008099:Liver / Q000196:embryology* / Q000378:metabolism*; D009952:Ornithine / Q000378:metabolism; D010101:Oxygen Consumption; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D019289:Pyruvic Acid / Q000378:metabolism; D012756:Sheep; D013004:Somatostatin / Q000008:administration & dosage*; D014471:Umbilical Veins / Q000378:metabolism*
chemical_list: D001786:Blood Glucose; D005973:Glutamine; D019344:Lactic Acid; D013004:Somatostatin; D019289:Pyruvic Acid; D005934:Glucagon; D001120:Arginine; D009952:Ornithine; D005947:Glucose; D000409:Alanine